Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2015

Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2683CTIDB
  • |
  • Pages: 59
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2015" provides data on the Zollinger-Ellison Syndrome (Gastrinoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Zollinger-Ellison Syndrome (Gastrinoma) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Zollinger-Ellison Syndrome (Gastrinoma) . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Zollinger-Ellison Syndrome (Gastrinoma) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Countries: Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by E7 Countries: Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials 16

Clinical Trials by Phase 17

In Progress Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Subjects Recruited Over a Period of Time 21

Clinical Trials by Sponsor Type 22

Prominent Sponsors 23

Top Companies Participating in Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials 24

Prominent Drugs 25

Clinical Trial Profiles 26

Clinical Trial Overview of Top Companies 26

AstraZeneca PLC 26

Clinical Trial Overview of AstraZeneca PLC 26

Chemo Espana, S.A. 27

Clinical Trial Overview of Chemo Espana, S.A. 27

Novartis AG 28

Clinical Trial Overview of Novartis AG 28

Aspen Pharmacare Holdings Ltd 29

Clinical Trial Overview of Aspen Pharmacare Holdings Ltd 29

Bluefish Pharmaceuticals AB 30

Clinical Trial Overview of Bluefish Pharmaceuticals AB 30

Takeda Pharmaceutical Company Limited 31

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 31

Eisai Co., Ltd. 32

Clinical Trial Overview of Eisai Co., Ltd. 32

Dr. Reddy's Laboratories Limited 33

Clinical Trial Overview of Dr. Reddy's Laboratories Limited 33

F. Hoffmann-La Roche Ltd. 34

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34

Ardelyx, Inc. 35

Clinical Trial Overview of Ardelyx, Inc. 35

Clinical Trial Overview of Top Institutes / Government 36

The National Institute of Diabetes and Digestive and Kidney Diseases 36

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 36

National Cancer Institute 37

Clinical Trial Overview of National Cancer Institute 37

Academic and Community Cancer Research United 38

Clinical Trial Overview of Academic and Community Cancer Research United 38

Eastern Cooperative Oncology Group 39

Clinical Trial Overview of Eastern Cooperative Oncology Group 39

Medical Co. LTA Clinical Pharmacology Center 40

Clinical Trial Overview of Medical Co. LTA Clinical Pharmacology Center 40

Stanford University 41

Clinical Trial Overview of Stanford University 41

University of Alabama at Birmingham 42

Clinical Trial Overview of University of Alabama at Birmingham 42

Five Key Clinical Profiles 43

Appendix 57

Abbreviations 57

Definitions 57

Research Methodology 58

Secondary Research 58

About GlobalData 59

Contact Us 59

Disclaimer 59

Source 59

List of Figures

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 16

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

GlobalData Methodology 58

List of Tables

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Region, 2015* 7

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 16

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Phase, 2015* 17

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 26

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2015* 27

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 28

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aspen Pharmacare Holdings Ltd, 2015* 29

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2015* 30

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 31

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 32

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015* 33

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 34

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ardelyx, Inc., 2015* 35

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 36

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 37

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic and Community Cancer Research United, 2015* 38

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2015* 39

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Co. LTA Clinical Pharmacology Center, 2015* 40

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015* 41

Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2015* 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

AstraZeneca PLC

Chemo Espana, S.A.

Novartis AG

Aspen Pharmacare Holdings Ltd

Bluefish Pharmaceuticals AB

Takeda Pharmaceutical Company Limited

Eisai Co., Ltd.

Dr. Reddy's Laboratories Limited

F. Hoffmann-La Roche Ltd.

Ardelyx, Inc.

Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Zollinger-Ellison Syndrome (Gastrinoma) , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license
Single User License
USD 2500 INR 178900
Site License
USD 5000 INR 357800
Corporate User License
USD 7500 INR 536700

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com